The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
This purpose of this study is to evaluate the pharmacokinetics (PK), safety, and tolerability of bedaquiline (BDQ) in...
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
A5329 is a study for people who are infected with both HIV and the Hepatitis C virus (HCV) and have never taken Hepatitis C...
The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...
